Literature DB >> 11739469

Differential expression of sulfotransferase enzymes involved in thyroid hormone metabolism during human placental development.

E L Stanley1, R Hume, T J Visser, M W Coughtrie.   

Abstract

Thyroid hormone is essential for normal human development, and disruption of thyroid hormone homeostasis at critical developmental stages can result in severe and often long-term effects on crucial organs such as the brain and lungs. Numerous factors control the bioavailability of receptor active thyroid hormone T(3). Sulfation, catalyzed by sulfotransferase enzymes (SULTs), is an important pathway of thyroid hormone metabolism by which T(4) is irreversibly converted to inactive reverse T(3) rather than active T(3). The human fetus and neonate have high levels of circulating sulfated iodothyronines, although the source of these is not clear. The placenta forms the link between the fetus and its mother and is involved in transfer of thyroid hormone early in pregnancy, although its capacity for sulfation is unknown. We therefore examined expression of the SULTs involved in iodothyronine metabolism during human placental development. SULT activity was measured in human placental cotyledon and membranes (amnion, chorion, and decidua basalis) from 13-42 wk of gestation, and Western blot analysis was employed to verify enzyme activity data. Phenol and catecholamine sulfotransferases were expressed at the highest levels and were generally higher in the villous than membranous tissues. SULT1A1 activity showed significant correlation with sulfation of 3,3'-T(2), suggesting that this enzyme is primarily responsible for placental T(2) sulfation. Estrogen sulfotransferase was present at extremely low levels during early pregnancy, although in mid- and late gestation increased expression in the (predominantly maternal-derived) decidual component of the placenta was observed. Hydroxysteroid sulfotransferase, T(3), reverse T(3), and T(4) SULT activities were also low in all tissues examined, and expression of SULTs 1B1 and 1C2 were essentially undetectable by Western blot analysis. The results highlight a tissue-specific regulation of SULT expression during placental development, demonstrate very low sulfation of iodothyronines suggesting that the placenta is not a major source of circulating sulfated iodothyronines in the fetus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739469     DOI: 10.1210/jcem.86.12.8081

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  The role of the placenta in thyroid hormone delivery to the fetus.

Authors:  Shiao Y Chan; Elisavet Vasilopoulou; Mark D Kilby
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

2.  On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

3.  Polybrominated diphenyl ether (PBDE) exposures and thyroid hormones in children at age 3 years.

Authors:  Ann M Vuong; Joseph M Braun; Glenys M Webster; R Thomas Zoeller; Andrew N Hoofnagle; Andreas Sjödin; Kimberly Yolton; Bruce P Lanphear; Aimin Chen
Journal:  Environ Int       Date:  2018-05-19       Impact factor: 9.621

4.  Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta.

Authors:  Margaret O James; Wenjun Li; David P Summerlot; Laura Rowland-Faux; Charles E Wood
Journal:  Environ Int       Date:  2009-03-18       Impact factor: 9.621

5.  MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells.

Authors:  Pallabi Mitra; Kenneth L Audus
Journal:  Int J Pharm       Date:  2009-09-25       Impact factor: 5.875

6.  Expression and functional activities of selected sulfotransferase isoforms in BeWo cells and primary cytotrophoblast cells.

Authors:  Pallabi Mitra; Kenneth L Audus
Journal:  Biochem Pharmacol       Date:  2009-07-30       Impact factor: 5.858

7.  Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate.

Authors:  Dongning He; Connie A Meloche; Nicole A Dumas; Andra R Frost; Charles N Falany
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

8.  Disruption of thyroid hormone sulfotransferase activity by brominated flame retardant chemicals in the human choriocarcinoma placenta cell line, BeWo.

Authors:  Christopher P Leonetti; Craig M Butt; Heather M Stapleton
Journal:  Chemosphere       Date:  2017-12-28       Impact factor: 7.086

9.  Sulfation of benzyl alcohol by the human cytosolic sulfotransferases (SULTs): a systematic analysis.

Authors:  Lingtian Zhang; Katsuhisa Kurogi; Ming-Yih Liu; Alaina M Schnapp; Frederick E Williams; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  J Appl Toxicol       Date:  2015-12-11       Impact factor: 3.446

10.  Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.

Authors:  S-Y Chan; J A Franklyn; H N Pemberton; J N Bulmer; T J Visser; C J McCabe; M D Kilby
Journal:  J Endocrinol       Date:  2006-06       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.